|
"An exceptionally well-balanced scientific discussion of
every aspect of psychedelic drugs... It is a courageous book
which simultaneously succeeds both for the popular and scientific
audiences." - Carl Sagan
"Our social policy has all but ignored the extraordinary
potential of psychedelic drugs for therapeutic use and inner
development. This book has played and will continue to play a
significant role in bringing the weight of scientific reason to bear
on re-opening the research opportunities that are a necessary
prerequisite for rectifying this situation." - Ram Dass "I
don't recall ever seeing a single book treat in so scholarly yet
lucid a fashion all of the historical, social and scientific aspects
of drugs with accuracy, balance, and thoughtful reflection." -
Solomon H. Snyder, M.D. Excerpts:
The
Lindesmith Center, a project of the Open Society Institute, is a
research institute dedicated to broadening the debate on drug policy
and related issues. ... The center's guiding principle is harm
reduction, an alternative approach to drug policy and treatment that
aims to minimize the adverse effects of drug abuse and punitive drug
prohibition. (page viii)
Psychedelic Drugs Reconsidered is the first book to be
republished as part of The Lindesmith Center's drug policy classics
reprint series. Grinspoon and Bakalar wrote this book in the
late 1970s, when the controversies of the 1960s seemed long past and
when research on psychedelics had virtually ground to a halt. Their
objective was principally intellectual: to record, synthesize, and
reflect upon a rich history of scientific research and societal
experience with psychedelics that was rapidly being forgotten. (page
xiii)
Is this book dangerous? Perhaps, in its capacity to stimulate
curiosity in a realm of drug use and personal exploration that is
almost entirely illegal, and not without risks. but those who hope
or fear to find in these pages a paean to psychedelic adventuring
will be disappointed. Grinspoon and Bakalar have written a sober and
comprehensive analysis of a complex subject that includes accounts
of extraordinary pleasure, insight, and ecstasy, but also intense
pain and fear. this book is most likely to be read by those who have
tried psychedelics, and thus find themselves tempted by its title.
but it is best read by those who have never tried these drugs, who
worry about those who have used or might use these drugs, and who
want to know the truth. (Ethan Nadelmann "Preface to the 1997
Edition," page xiii)
The therapeutic promise of psychedelic drugs is still unfulfilled,
but new prospects have emerged. Therapists may be able to take
renewed inspiration from the ancient traditions of religious
psychedelic use — always one of the places where spirituality and
psychotherapy have converged. The use of peyote by North American
Indians has been legitimized by the Indian Religious Freedom Act of
1994, which prohibits the passage of state laws banning the services
of the Native American Church. In a recent study of the sacramental
use of ayahuasca by Amazon Indians, researchers have found
that like peyote, it serves as a treatment for alcoholism. Rick
Doblin, the most zealous and effective advocate of continued
psychedelic drug research, has reviewed the Good Friday experiment
(described on pages 280-281) after twenty-five years and found that
most of the men who took psilocybin still thought the experience had
genuine mystical features. They believed that the positive changes
they reported in the original study had persisted and sometimes
deepened over the years, and they said the experience had enhanced
their appreciation of life and deepened their commitment to a
religious vocation. (pages xx-xxi)
CSP's
Entheogen
Chrestomathy entry for Psychedelic Drugs Reconsidered
Submit
a review of your own
|